Cite as https://mymun.com/ppdb/3412
Topic A: Intellectual Property Rights and HIV/AIDS Medication
The People’s Republic of Bangladesh is alarmed by the global increasing rate of the disease of HIV and AIDS, which affected 36.9 million people in 2014. According to the UNAIDS’ report in 2014, Bangladesh has a low HIV/AIDS prevalence rate, which is less than 0.1%. However, migrant workers are one of the most-at-risk populations, their prevalence rate being high as 2.7%. The National AIDS/STD report in 2006 stressed that returning migrant workers and their spouses represented 67% of the country’s HIV positive cases.
In 1985, Bangladesh created the National AIDS Committee (NAC), aiming to implement effective protection measures and policies. The government implemented in 1997 its national HIV and AIDS Policy, which is unique, elaborated and comprehensive since it addresses important aspects such as human rights, gender, education and communication. Throughout the past decades, the government has been collaborating with more than two hundred NGOS to prevent and seek treatments regarding the disease of HIV and AIDS. Bangladesh receives funding from several sources such as The Ministry of Health and Family Welfare, the Global Fund for AIDS, World Bank, USAID and others. Regarding the production of pharmaceutical drugs, Bangladesh is a major export of generic drugs to 85 countries, their worth estimated to 50 million dollars in 2011. Bangladesh is a signatory of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement and believes that i...